Follow
Silvia Goldoni
Silvia Goldoni
Senior Scientist, Research and Early Development Oncology, Bayer Pharmaceuticals, Cambridge MA, USA
Verified email at bayer.com
Title
Cited by
Cited by
Year
BCR/ABL activates mdm2 mRNA translation via the La antigen
R Trotta, T Vignudelli, O Candini, RV Intine, L Pecorari, C Guerzoni, ...
Cancer cell 3 (2), 145-160, 2003
2732003
Genetic evidence for the coordinated regulation of collagen fibrillogenesis in the cornea by decorin and biglycan
G Zhang, S Chen, S Goldoni, BW Calder, HC Simpson, RT Owens, ...
Journal of Biological Chemistry 284 (13), 8888-8897, 2009
2622009
Decorin is a novel antagonistic ligand of the Met receptor
S Goldoni, A Humphries, A Nyström, S Sattar, RT Owens, DJ McQuillan, ...
Journal of Cell Biology 185 (4), 743-754, 2009
2602009
Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis
JX Zhu, S Goldoni, G Bix, RT Owens, DJ McQuillan, CC Reed, RV Iozzo
Journal of Biological Chemistry 280 (37), 32468-32479, 2005
2252005
Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation
DG Seidler, S Goldoni, C Agnew, C Cardi, ML Thakur, RT Owens, ...
Journal of Biological Chemistry 281 (36), 26408-26418, 2006
2242006
Tumor microenvironment: Modulation by decorin and related molecules harboring leucine‐rich tandem motifs
S Goldoni, RV Iozzo
International journal of cancer 123 (11), 2473-2479, 2008
2032008
An antimetastatic role for decorin in breast cancer
S Goldoni, DG Seidler, J Heath, M Fassan, R Baffa, ML Thakur, RT Owens, ...
The American journal of pathology 173 (3), 844-855, 2008
1882008
Cell-geometry-dependent changes in plasma membrane order direct stem cell signalling and fate
TC von Erlach, S Bertazzo, MA Wozniak, CM Horejs, SA Maynard, ...
Nature materials 17 (3), 237-242, 2018
1842018
Biologically active decorin is a monomer in solution
S Goldoni, RT Owens, DJ McQuillan, Z Shriver, R Sasisekharan, DE Birk, ...
Journal of biological chemistry 279 (8), 6606-6612, 2004
1402004
Combinations with allosteric SHP2 inhibitor TNO155 to block receptor tyrosine kinase signaling
C Liu, H Lu, H Wang, A Loo, X Zhang, G Yang, C Kowal, S Delach, ...
Clinical Cancer Research 27 (1), 342-354, 2021
1282021
A soluble ectodomain of LRIG1 inhibits cancer cell growth by attenuating basal and ligand-dependent EGFR activity
S Goldoni, RA Iozzo, P Kay, S Campbell, A McQuillan, C Agnew, JX Zhu, ...
Oncogene 26 (3), 368-381, 2007
1262007
Proepithelin regulates prostate cancer cell biology by promoting cell growth, migration, and anchorage-independent growth
G Monami, V Emiliozzi, A Bitto, F Lovat, SQ Xu, S Goldoni, M Fassan, ...
The American journal of pathology 174 (3), 1037-1047, 2009
922009
Small leucine-rich proteoglycans
RV Iozzo, S Goldoni, AD Berendsen, MF Young
The extracellular matrix: an overview, 197-231, 2011
602011
Functionalized Poly(ã‐Glutamic Acid) Fibrous Scaffolds for Tissue Engineering
C Gentilini, Y Dong, JR May, S Goldoni, DE Clarke, BH Lee, ET Pashuck, ...
Advanced healthcare materials 1 (3), 308-315, 2012
542012
SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
Y Wang, M Mohseni, A Grauel, JE Diez, W Guan, S Liang, JE Choi, M Pu, ...
Scientific reports 11 (1), 1399, 2021
522021
A central role for decorin during vertebrate convergent extension
JJ Zoeller, W Pimtong, H Corby, S Goldoni, AE Iozzo, RT Owens, SY Ho, ...
Journal of Biological Chemistry 284 (17), 11728-11737, 2009
502009
MITOSTATIN, a putative tumor suppressor on chromosome 12q24. 1, is downregulated in human bladder and breast cancer
A Vecchione, M Fassan, V Anesti, A Morrione, S Goldoni, G Baldassarre, ...
Oncogene 28 (2), 257-269, 2009
502009
Enzymatically cross‐linked gelatin/chitosan hydrogels: tuning gel properties and cellular response
MA Da Silva, F Bode, AF Drake, S Goldoni, MM Stevens, CA Dreiss
Macromolecular bioscience 14 (6), 817-830, 2014
492014
Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade
K Sehgal, A Portell, EV Ivanova, PH Lizotte, NR Mahadevan, JR Greene, ...
The Journal of clinical investigation 131 (2), 2021
472021
Proepithelin is an autocrine growth factor for bladder cancer
F Lovat, A Bitto, SQ Xu, M Fassan, S Goldoni, D Metalli, V Wubah, ...
Carcinogenesis 30 (5), 861-868, 2009
472009
The system can't perform the operation now. Try again later.
Articles 1–20